241 related articles for article (PubMed ID: 17600643)
1. Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.
Devarakonda B; Otto DP; Judefeind A; Hill RA; de Villiers MM
Int J Pharm; 2007 Dec; 345(1-2):142-53. PubMed ID: 17600643
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins.
Devarakonda B; Hill RA; Liebenberg W; Brits M; de Villiers MM
Int J Pharm; 2005 Nov; 304(1-2):193-209. PubMed ID: 16198076
[TBL] [Abstract][Full Text] [Related]
3. Solubility of nicotinic acid in polyamidoamine dendrimer solutions.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Dec; 40(12):1384-9. PubMed ID: 16226352
[TBL] [Abstract][Full Text] [Related]
4. Computationally efficient methodology for atomic-level characterization of dendrimer-drug complexes: a comparison of amine- and acetyl-terminated PAMAM.
Vergara-Jaque A; Comer J; Monsalve L; González-Nilo FD; Sandoval C
J Phys Chem B; 2013 Jun; 117(22):6801-13. PubMed ID: 23642174
[TBL] [Abstract][Full Text] [Related]
5. Polyamidoamine Starburst dendrimers as solubility enhancers.
Milhem OM; Myles C; McKeown NB; Attwood D; D'Emanuele A
Int J Pharm; 2000 Mar; 197(1-2):239-41. PubMed ID: 10704811
[TBL] [Abstract][Full Text] [Related]
6. Polyamidoamine dendrimers used as solubility enhancers of ketoprofen.
Yiyun C; Tongwen X; Rongqiang F
Eur J Med Chem; 2005 Dec; 40(12):1390-3. PubMed ID: 16226353
[TBL] [Abstract][Full Text] [Related]
7. Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.
Kolhe P; Misra E; Kannan RM; Kannan S; Lieh-Lai M
Int J Pharm; 2003 Jun; 259(1-2):143-60. PubMed ID: 12787643
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Polyamidoamine Dendrimer for Encapsulating Tetramethylscutellarein for Potential Bioactivity Enhancement.
Shadrack DM; Mubofu EB; Nyandoro SS
Int J Mol Sci; 2015 Nov; 16(11):26363-77. PubMed ID: 26556337
[TBL] [Abstract][Full Text] [Related]
9. PAMAM dendrimers for the delivery of the antibacterial Triclosan.
Gardiner J; Freeman S; Leach M; Green A; Alcock J; D'Emanuele A
J Enzyme Inhib Med Chem; 2008 Oct; 23(5):623-8. PubMed ID: 18821252
[TBL] [Abstract][Full Text] [Related]
10. Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes.
Yang W; de Villiers MM
J Pharm Pharmacol; 2004 Jun; 56(6):703-8. PubMed ID: 15231034
[TBL] [Abstract][Full Text] [Related]
11. Poly (amidoamine) dendrimer-mediated hybrid formulation for combination therapy of ramipril and hydrochlorothiazide.
Singh MK; Pooja D; Kulhari H; Jain SK; Sistla R; Chauhan AS
Eur J Pharm Sci; 2017 Jan; 96():84-92. PubMed ID: 27614111
[TBL] [Abstract][Full Text] [Related]
12. Dendrimers as potential drug carriers. Part I. Solubilization of non-steroidal anti-inflammatory drugs in the presence of polyamidoamine dendrimers.
Yiyun C; Tongwen X
Eur J Med Chem; 2005 Nov; 40(11):1188-92. PubMed ID: 16153746
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of polyamidoamine dendrimers and their complexes with linear poly(ethylene oxide) at different pH conditions: static properties and hydrogen bonding.
Tanis I; Karatasos K
Phys Chem Chem Phys; 2009 Nov; 11(43):10017-28. PubMed ID: 19865754
[TBL] [Abstract][Full Text] [Related]
14. PAMAM dendrimer-drug interactions: effect of pH on the binding and release pattern.
Maingi V; Kumar MV; Maiti PK
J Phys Chem B; 2012 Apr; 116(14):4370-6. PubMed ID: 22420638
[TBL] [Abstract][Full Text] [Related]
15. Association of the anti-tuberculosis drug rifampicin with a PAMAM dendrimer.
Bellini RG; Guimarães AP; Pacheco MA; Dias DM; Furtado VR; de Alencastro RB; Horta BA
J Mol Graph Model; 2015 Jul; 60():34-42. PubMed ID: 26093506
[TBL] [Abstract][Full Text] [Related]
16. The interaction mechanism between lipopeptide (daptomycin) and polyamidoamine (PAMAM) dendrimers.
Chanvorachote B; Qiu J; Muangsiri W; Nimmannit U; Kirsch LE
J Pept Sci; 2015 Apr; 21(4):312-9. PubMed ID: 25694356
[TBL] [Abstract][Full Text] [Related]
17. Bundling and aggregation of DNA by cationic dendrimers.
Froehlich E; Mandeville JS; Weinert CM; Kreplak L; Tajmir-Riahi HA
Biomacromolecules; 2011 Feb; 12(2):511-7. PubMed ID: 21192723
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug.
Ma M; Cheng Y; Xu Z; Xu P; Qu H; Fang Y; Xu T; Wen L
Eur J Med Chem; 2007 Jan; 42(1):93-8. PubMed ID: 17095123
[TBL] [Abstract][Full Text] [Related]
19. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
20. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex.
Patri AK; Kukowska-Latallo JF; Baker JR
Adv Drug Deliv Rev; 2005 Dec; 57(15):2203-14. PubMed ID: 16290254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
